Search Results

There are 12238 results for: content related to: Additive effect of sirolimus and anti-death receptor 5 agonistic antibody against hepatocellular carcinoma

  1. You have free access to this content
    Induction of proapoptotic antibodies to triple-negative breast cancer by vaccination with TRAIL death receptor DR5 DNA

    International Journal of Cancer

    Volume 131, Issue 11, 1 December 2012, Pages: 2562–2572, Marie P. Piechocki, Gen Sheng Wu, Richard F. Jones, Jennifer B. Jacob, Heather Gibson, Stephen P. Ethier, Judith Abrams, Hideo Yagita, K Venuprasad and Wei-Zen Wei

    Version of Record online : 24 APR 2012, DOI: 10.1002/ijc.27534

  2. You have free access to this content
    Treatment of arthritis by macrophage depletion and immunomodulation: Testing an apoptosis-mediated therapy in a humanized death receptor mouse model

    Arthritis & Rheumatism

    Volume 64, Issue 4, April 2012, Pages: 1098–1109, Jun Li, Hui-Chen Hsu, PingAr Yang, Qi Wu, Hao Li, Laura E. Edgington, Matthew Bogyo, Robert P. Kimberly and John D. Mountz

    Version of Record online : 27 MAR 2012, DOI: 10.1002/art.33423

  3. Enhanced DR5 binding capacity of nanovectorized TRAIL compared to its cytotoxic version by affinity chromatography and molecular docking studies

    Journal of Molecular Recognition

    Volume 29, Issue 9, September 2016, Pages: 406–414, Albatoul Zakaria, Fabien Picaud, Yves Claude Guillaume, Tijani Gharbi, Olivier Micheau and Guillaume Herlem

    Version of Record online : 7 MAR 2016, DOI: 10.1002/jmr.2539

  4. Calmodulin Binding to Death Receptor 5-mediated Death-Inducing Signaling Complex in Breast Cancer Cells

    Journal of Cellular Biochemistry

    Volume 118, Issue 8, August 2017, Pages: 2285–2294, Romone M. Fancy, Harrison Kim, Tong Zhou, Kurt R. Zinn, Donald J. Buchsbaum and Yuhua Song

    Version of Record online : 12 APR 2017, DOI: 10.1002/jcb.25882

  5. You have free access to this content
    Role and prognostic significance of tumor necrosis factor-related apoptosis-inducing ligand death receptor DR5 in nonsmall-cell lung cancer and precursor lesions

    Cancer

    Volume 113, Issue 1, 1 July 2008, Pages: 135–142, Wendy A. Cooper, Maija R.J. Kohonen-Corish, Liqing Zhuang, Brian McCaughan, Catherine Kennedy, Gavin Screaton, Robert L. Sutherland and C-Soon Lee

    Version of Record online : 5 MAY 2008, DOI: 10.1002/cncr.23528

  6. You have free access to this content
    Synthetic constrained peptide selectively binds and antagonizes death receptor 5

    The FEBS Journal

    Volume 277, Issue 7, April 2010, Pages: 1653–1665, Johanna Vrielink, Mariette S. Heins, Rita Setroikromo, Eva Szegezdi, Margaret M. Mullally, Afshin Samali and Wim J. Quax

    Version of Record online : 12 FEB 2010, DOI: 10.1111/j.1742-4658.2010.07590.x

  7. You have free access to this content
    Death Receptor 5–Targeted Depletion of Interleukin-23–Producing Macrophages, Th17, and Th1/17 Associated With Defective Tyrosine Phosphatase in Mice and Patients With Rheumatoid Arthritis

    Arthritis & Rheumatism

    Volume 65, Issue 10, October 2013, Pages: 2594–2605, Jun Li, PingAr Yang, Qi Wu, Hao Li, Yanna Ding, Hui-Chen Hsu, David M. Spalding and John D. Mountz

    Version of Record online : 24 SEP 2013, DOI: 10.1002/art.38057

  8. Quercetin sensitizes human hepatoma cells to TRAIL-induced apoptosis via Sp1-mediated DR5 up-regulation and proteasome-mediated c-FLIPS down-regulation

    Journal of Cellular Biochemistry

    Volume 105, Issue 6, 15 December 2008, Pages: 1386–1398, Jin Yeop Kim, Eun Hee Kim, Seok Soon Park, Jun Hee Lim, Taeg Kyu Kwon and Kyeong Sook Choi

    Version of Record online : 3 NOV 2008, DOI: 10.1002/jcb.21958

  9. You have free access to this content
    TRAIL receptor upregulation and the implication of KRAS/BRAF mutations in human colon cancer tumors

    International Journal of Cancer

    Volume 125, Issue 9, 1 November 2009, Pages: 2127–2135, Eftychia Oikonomou, Vivian Kosmidou, Anastasia Katseli, Konstantinos Kothonidis, Despina Mourtzoukou, George Kontogeorgos, Ladislav Andera, Georgios Zografos and Alexander Pintzas

    Version of Record online : 2 JUN 2009, DOI: 10.1002/ijc.24613

  10. You have full text access to this Open Access content
    Salermide up-regulates death receptor 5 expression through the ATF4-ATF3-CHOP axis and leads to apoptosis in human cancer cells

    Journal of Cellular and Molecular Medicine

    Volume 16, Issue 7, July 2012, Pages: 1618–1628, Guangbo Liu, Ling Su, Xuexi Hao, Ning Zhong, Diansheng Zhong, Sunil Singhal and Xiangguo Liu

    Version of Record online : 28 JUN 2012, DOI: 10.1111/j.1582-4934.2011.01401.x

  11. You have free access to this content
    YM155 sensitizes triple-negative breast cancer to membrane-bound TRAIL through p38 MAPK- and CHOP-mediated DR5 upregulation

    International Journal of Cancer

    Volume 136, Issue 2, 15 January 2015, Pages: 299–309, Marzia Pennati, Stefania Sbarra, Michelandrea De Cesare, Alessia Lopergolo, Silvia L. Locatelli, Elisa Campi, Maria Grazia Daidone, Carmelo Carlo-Stella, Alessandro M. Gianni and Nadia Zaffaroni

    Version of Record online : 5 JUN 2014, DOI: 10.1002/ijc.28993

  12. α-TEA induces apoptosis of human breast cancer cells via activation of TRAIL/DR5 death receptor pathway

    Molecular Carcinogenesis

    Volume 49, Issue 11, November 2010, Pages: 964–973, Weiping Yu, Richa Tiwary, Jing Li, Sook-Kyung Park, Li Jia, Ailian Xiong, Marla Simmons-Menchaca, Bob G. Sanders and Kimberly Kline

    Version of Record online : 30 SEP 2010, DOI: 10.1002/mc.20681

  13. Vernodalol enhances TRAIL-induced apoptosis in diffuse large B-cell lymphoma cells

    Molecular Carcinogenesis

    Wenjun Wu, Yang Yang, Gang Deng, Liang Ma, Guoqing Wei, Gaofeng Zheng, Xiaoyan Han, Donghua He, Yi Zhao, Jinsong He, Zhen Cai and Rui Yu

    Version of Record online : 15 MAY 2017, DOI: 10.1002/mc.22672

  14. You have free access to this content
    Upregulation of DR5 by proteasome inhibitors potently sensitizes glioma cells to TRAIL-induced apoptosis

    The FEBS Journal

    Volume 275, Issue 8, April 2008, Pages: 1925–1936, Holger Hetschko, Valerie Voss, Volker Seifert, Jochen H. M. Prehn and Donat Kögel

    Version of Record online : 13 MAR 2008, DOI: 10.1111/j.1742-4658.2008.06351.x

  15. Thioether Analogues of Disulfide-Bridged Cyclic Peptides Targeting Death Receptor 5: Conformational Analysis, Dimerisation and Consequences for Receptor Activation

    ChemBioChem

    Volume 16, Issue 2, January 19, 2015, Pages: 293–301, Dr. Karolina Pulka-Ziach, Dr. Valeria Pavet, Neila Chekkat, Dr. Karine Estieu-Gionnet, Roman Rohac, Dr. Marie-Charlotte Lechner, Dr. Cristian R. Smulski, Dr. Gabrielle Zeder-Lutz, Dr. Danièle Altschuh, Dr. Hinrich Gronemeyer, Prof. Dr. Sylvie Fournel, Dr. Benoit Odaert and Dr. Gilles Guichard

    Version of Record online : 8 DEC 2014, DOI: 10.1002/cbic.201402485

  16. You have free access to this content
    Rheumatoid arthritis synovial fluid fibroblasts express TRAIL-R2 (DR5) that is functionally active

    Arthritis & Rheumatism

    Volume 50, Issue 9, September 2004, Pages: 2786–2793, María-Eugenia Miranda-Carús, Alejandro Balsa, Marta Benito-Miguel, Carlos Pérez de Ayala and Emilio Martín-Mola

    Version of Record online : 9 SEP 2004, DOI: 10.1002/art.20501

  17. You have free access to this content
    Promoter structure and transcription initiation sites of the human death receptor 5/TRAIL-R2 gene1

    FEBS Letters

    Volume 507, Issue 3, November 02, 2001, Pages: 381–385, Tatsushi Yoshida, Ayaka Maeda, Naoki Tani and Toshiyuki Sakai

    Version of Record online : 2 NOV 2001, DOI: 10.1016/S0014-5793(01)02947-7

  18. You have free access to this content
    The chalcone 2′-hydroxy-4′,5′-dimethoxychalcone activates death receptor 5 pathway and leads to apoptosis in human nonsmall cell lung cancer cells

    IUBMB Life

    Volume 65, Issue 6, June 2013, Pages: 533–543, Lina Yang, Ling Su, Congmei Cao, Linyan Xu, Diansheng Zhong, Lijia Xu and Xiangguo Liu

    Version of Record online : 3 APR 2013, DOI: 10.1002/iub.1161

  19. You have full text access to this Open Access content
    Lipoxygenase inhibitors induce death receptor 5/TRAIL-R2 expression and sensitize malignant tumor cells to TRAIL-induced apoptosis

    Cancer Science

    Volume 98, Issue 9, September 2007, Pages: 1417–1423, Tatsushi Yoshida, Takumi Shiraishi, Mano Horinaka, Susumu Nakata, Takashi Yasuda, Ahmed E. Goda, Miki Wakada, Yoichi Mizutani, Tsuneharu Miki, Akiyoshi Nishikawa and Toshiyuki Sakai

    Version of Record online : 23 JUL 2007, DOI: 10.1111/j.1349-7006.2007.00559.x

  20. You have full text access to this Open Access content
    Stem cells are resistant to TRAIL receptor-mediated apoptosis

    Journal of Cellular and Molecular Medicine

    Volume 13, Issue 11-12, November-December 2009, Pages: 4409–4414, Eva Szegezdi, Aoife O’Reilly, Yeung Davy, Reaz Vawda, Deanna L. Taylor, Mary Murphy, Afshin Samali and Huseyin Mehmet

    Version of Record online : 13 OCT 2008, DOI: 10.1111/j.1582-4934.2008.00522.x